GT Biopharma's total assets for Q3 2024 were $6.76M, a decrease of -27.06% from the previous quarter. GTBP total liabilities were $4.66M for the fiscal quarter, a 24.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.